Aug
10

NY’s workers comp fee schedule – further developments

The recent imposition of a work comp pharmacy fee schedule in New York has shaken the industry – and that’s not hyperbole. The latest news out of Albany is likely to intensify the aftershocks.
The preliminary guidance from the State is PBMs cannot charge more than the fee schedule, and cannot pay pharmacies more than the fee schedule.

Continue reading NY’s workers comp fee schedule – further developments


Aug
7

Medicare sneezes

The adage goes something like – when the US sneezes, the world catches a cold, signifying just how much influence this country has on the rest of the world.
That’s analogous to Medicare’s impact on the health care sector. And Medicare is about to change the way it pays hospitals, a change that will have a dramatic effect on every private payer from HMO to individual carrier to workers comp insurer to self-insured employer.

Continue reading Medicare sneezes


Aug
6

CMS denies off-label Actiq coverage

The latest shot in the battle against drug costs comes from the Centers for Medicaid and Medicare Services, which is reported to be denying coverage for off-label use of drugs such as Actiq and Fentora.
Whenever CMS moves, the healthcare world shakes, and this is no exception. There are a host of possible ‘downstream implications’ in areas as diverse as workers comp, formulary management, and hospice.

Continue reading CMS denies off-label Actiq coverage


Jul
17

Will the soft market in workers comp persist?

The workers comp market is still soft, with rates continuing to decline. However, the rate of decline has leveled off somewhat, with the latest stats indicating a decrease of less than 2% in the second quarter.
While some think the tapering off is due to the effect of the California and Florida reforms tapering off, I’m not so sure.

Continue reading Will the soft market in workers comp persist?